Maximus Declares Quarterly Cash Dividend, Payable on November 30, 2026
Maximus (NYSE: MMS) has announced that its Board of Directors approved a quarterly cash dividend of $0.33 per share. This dividend is payable on November 30, 2026, to shareholders who are on record as of November 13, 2026.
Maximus Declares Quarterly Cash Dividend of $0.33 Per Share
Maximus (NYSE: MMS) announced that its Board of Directors has approved a quarterly cash dividend of $0.33 per share. The dividend is payable on November 30, 2026, to shareholders of record as of November 13, 2026. Maximus is a leading provider of government services, offering tech-enabled solutions to improve public service delivery.
MAXIMUS (MMS) Declares Quarterly Dividend of $0.33, Yielding 2.5
Maximus Inc. (MMS) has declared a quarterly dividend of $0.33 per share, maintaining its payout for the fourth consecutive quarter, resulting in an attractive forward yield of 2.51%. The company appears significantly undervalued with a GF Value™ of $91.30 against its current price of $52.65, and its GF Score™ of 77 indicates strong financial health and profitability. Despite some insider selling, institutional interest remains positive, making MMS a compelling option for income-focused investors.
Maximus declares $0.33 quarterly dividend By Investing.com
Maximus (NYSE:MMS) announced a quarterly cash dividend of $0.33 per share, payable on November 30, 2026, to shareholders of record as of November 13, 2026. The company provides government services, including business process management and technology solutions. This article was generated with AI support and reviewed by an editor.
Maximus Keeps Quarterly Dividend at $0.33 a Share, Payable Nov. 30 to Shareholders of Record on Nov. 13
Maximus, Inc. announced it will maintain its quarterly dividend at $0.33 per share. This dividend is scheduled to be paid on November 30, 2026, to shareholders who are on record as of November 13, 2026. The announcement was made on October 5, 2026, at 06:51 am EDT.
To cover vesting taxes, Maximus (MMS) CFO David Mutryn surrenders 4,749 shares.
Maximus, Inc. CFO David Mutryn surrendered 4,749 shares of common stock on September 30, 2026, to cover withholding taxes related to vesting restricted stock units. The transaction was valued at $53.19 per share, leaving his direct holdings at 35,614 shares, including dividend equivalents. This insider transaction was filed as a Form 4, indicating a tax withholding event.
To cover stock award taxes, Maximus (MMS) officer surrenders 1,244 shares at $53.19 each.
Maximus, Inc.'s Principal Accounting Officer, Theresa D. Golinvaux, surrendered 1,244 shares of common stock on September 30, 2026, to cover withholding taxes related to vesting restricted stock units. The shares were valued at $53.19 each. Following this transaction, Golinvaux directly holds 12,349 shares of Maximus stock.
At $54.23 a share, Maximus (MMS) HR chief sells 3,208 shares under a trading plan.
Maximus, Inc.'s Chief of Human Resources, Michelle F. Link, sold 3,208 shares of common stock at $54.23 per share on October 1, 2026, as part of a pre-arranged 10b5-1 trading plan. Additionally, 2,637 shares were surrendered on September 30, 2026, to cover tax withholdings related to vesting restricted stock units. Following these transactions, Link directly holds 13,880.851 shares of common stock.
After 713 shares are withheld for taxes, Maximus (MMS) counsel holds 4,382 shares.
Maximus General Counsel and Corp. Sec. Elizabeth Moellering had 713 shares withheld on September 30, 2026, to cover tax obligations related to the vesting of restricted stock units. The shares were valued at $53.19 each. Following this transaction, Moellering directly holds 4,382 shares of Maximus, which includes accrued dividend equivalents.
Maximus, Inc. (MMS) Stock Forecasts
Argus has lowered its price target for Maximus, Inc. (MMS) to $50.00 from its current price of $52.65. Maximus Inc. specializes in designing and delivering programs that help people access vital government services, translating public policy into operational models. The report, dated September 30, 2026, is part of a quantitative analysis within the industrials sector.
Maximus, Inc. (MMS) Stock Price, News, Quote & History
Maximus, Inc. (MMS) stock closed at $52.65, down 1.64%, with an after-hours price remaining stable. The company specializes in government services, operating across U.S. Federal, U.S. State, and international segments. Its stock performance shows significant year-to-date and annual returns, outperforming the S&P 500, with analysts giving an average price target of $92.50.
An officer proposes selling 3,208 Maximus (MMS) shares received through stock vesting.
Maximus (MMS) officer Michelle F. Link has filed a Form 144, proposing to sell 3,208 common shares valued at $173,969.84. These shares were received as compensation from restricted stock vesting on September 30, 2026, with an approximate sale date of October 1, 2026, through Fidelity Brokerage Services LLC. The filing provides key details about the proposed sale, the company's shares outstanding, and definitions of relevant financial terms.
Is Maximus (MMS) Undervalued Following Its Recent Share Price Slide?
Maximus (MMS) has experienced a share price slide over the past month and three months, prompting investors to re-evaluate its valuation. Despite the recent decline, Simply Wall St's analysis suggests that Maximus is 43% undervalued with a fair value of $92.50, significantly higher than its current $52.61. This undervaluation is attributed to the company's strong position in the public sector digital transformation and its ability to secure new federal contracts, although risks like client insourcing or budget cuts could impact its narrative.
Human services modernization featured in Policy & Practice
Maximus experts David Crowson and Pat Aguilar discuss human services modernization in a recent Policy & Practice article. They outline a three-stage approach—stabilize, redesign, and scale—to help state SNAP agencies improve performance while preparing for long-term transformation. This approach helps agencies address challenges like workforce shortages and federal scrutiny by aligning people, processes, and technology.
Maximus Inc stock hits 52-week low at 52.72 USD By Investing.com
Maximus Inc (MMS) stock has fallen to a 52-week low of $52.72, representing a 39.9% decrease over the past year and a 37% year-to-date decline. Despite this, InvestingPro analysis suggests the stock is undervalued with a P/E ratio of 7.83 and a 2.45% dividend yield, having paid dividends for 22 consecutive years. The company recently reported mixed Q3 results, beating earnings estimates but missing on revenue, and adjusted its full-year profit outlook due to a temporary pause in incentives on a Veterans Affairs contract.
Maximus Inc stock hits 52-week low at 52.72 USD
Maximus Inc. (MMS) stock has fallen to a 52-week low of $52.72, representing a 39.9% decrease over the past year and a 47% decline from its 52-week high. Despite the downturn, InvestingPro analysis suggests the stock is significantly undervalued with a P/E ratio of 7.83 and a 2.45% dividend yield, having paid dividends for 22 consecutive years. The company recently reported mixed Q3 results with adjusted earnings beating forecasts but revenue falling short, alongside a revised full-year profit outlook due to a temporary pause in incentives on a Veterans Affairs contract.
Strong Technology and a Low Stock Price Make Maximus (MMS) a Good Target for Acquisition
Maximus (MMS) delivered Q3 fiscal 2026 results showing operational resilience despite a revenue decline, positioning it as an attractive acquisition target. The company maintained margin discipline, grew earnings per share, and has a substantial sales pipeline and emerging AI capabilities. Its low stock valuation, strong balance sheet, and high-margin federal services segment make it appealing to larger government services integrators or defense contractors.
Maximus’ (MMS) Tech Capabilities and Beaten-Down Valuation Point to M&A Upside
Third Avenue Small-Cap Value Fund initiated a position in Maximus, Inc. (MMS) in Q2 2026, despite its recent stock decline. The fund views Maximus, a government services company specializing in technology-forward consulting, as undervalued given its strong technological capabilities and institutional knowledge in government program administration. They believe the company's valuation presents an attractive opportunity, especially with management's confidence in operational guidance and the use of AI to improve margins.
Mobile medical clinics expand Veterans’ access to disability exams and diagnostic services
Veterans Evaluation Services (VES), a Maximus company, is expanding its Mobile Medical Clinic program to offer enhanced diagnostic services and disability exams to Veterans, especially those in rural and remote areas. These wheelchair-accessible mobile units are staffed by board-certified clinicians and equipped with modern technology to provide timely and high-quality care, helping to reduce wait times and improve access for Veterans. Since its inception, the program has supported over 1,500 mobile clinic events and served more than 800 locations, significantly improving equitable access to essential medical services.
Deutsche Bank AG Makes New Investment in Maximus, Inc. $MMS
Deutsche Bank AG has acquired a new stake in Maximus, Inc. (NYSE:MMS), purchasing 328,007 shares valued at approximately $17.6 million, which gives them a 0.62% ownership. This comes as analyst sentiment for Maximus has weakened, with Zacks Research downgrading the stock to "strong sell" and Wall Street Zen cutting its rating to "hold." Despite slightly beating EPS estimates, the company missed revenue expectations and saw a 5.1% year-over-year sales decline.
HCI Group Stock And 2 Underfollowed Financial Stocks For Higher Rate Markets
This article identifies three underfollowed small-cap financial stocks—Maximus (MMS), Exzeo Group (XZO), and HCI Group (HCI)—that could thrive in a high-interest-rate environment. These companies, highlighted from the "High Quality Undiscovered Gems" screener, offer resilience and growth potential by operating in areas like government services modernization and InsurTech, despite potential risks like contract concentration or reliance on external factors. The article suggests these stocks could be valuable additions to a long-term portfolio before they gain widespread institutional attention.
How Investors Are Reacting To Maximus (MMS) Q3 Results And Updated 2026 Profit Guidance
Maximus Inc. (MMS) reported Q3 fiscal results and updated its full-year 2026 guidance, with revenue projected to be US$5.2–US$5.35 billion and net income US$376–US$392 million. The company reaffirmed its focus on disciplined acquisitions and share repurchases within a target net debt ratio of 2x–3x. This strategy aims to expand capabilities and customer access, driving revenue synergies and maintaining financial stability amid potential contract volume and budget pressures.
How Investors Are Reacting To Maximus (MMS) Q3 Results And Updated 2026 Profit Guidance
Maximus, Inc. reported its Q3 results with strong revenue and net income, and updated its 2026 full-year guidance, which includes revenue between US$5.2 billion and US$5.35 billion. The company emphasized its continued focus on disciplined acquisitions and share repurchases, aiming for revenue synergies while maintaining a net debt ratio of 2x-3x. This strategy reinforces the investment narrative centered on government outsourcing, margin improvement through technology, and controlled capital deployment, with some analysts projecting significant upside to its current stock price.
Q3 2026 Maximus Inc Earnings Call Transcript
Maximus Inc. (MMS) reported strong Q3 fiscal 2026 results with revenue aligning with expectations and adjusted EPS showing an increase. Despite improvements in adjusted EBITDA margin and US Federal Services operating margin, a customer-directed pause in performance incentives on the VA Medical Disability Exam (VAMDE) program is expected to negatively impact Q4 and Q1 fiscal 2027 earnings, leading to a revised EPS guidance. The company faces challenges including declining revenues in some segments, negative cash flow from operations due to administrative delays, and a slower pace of new contract signings.
Maximus (MMS) Flags Revenue Uncertainty, Is The Stock Still Undervalued?
Maximus (MMS) has drawn investor attention after its fiscal 2026 third-quarter results and updated guidance indicated revenue near the lower end of expectations, citing contract delays and weaker award conversion. Despite a 35.17% year-to-date share price decline, the company is still considered 43.9% undervalued with a fair value of $100 based on expectations of expanded demand due to new federal legislation. However, this valuation depends on timely contract rollouts and assumes no insourcing or client shifts to competitors.
Walleye Capital LLC Takes Position in Maximus, Inc. $MMS
Walleye Capital LLC has acquired a new stake in Maximus, Inc. (NYSE:MMS), purchasing 384,021 shares valued at approximately $20.6 million. This move comes as institutional investors collectively own 97.21% of Maximus, despite recent analyst downgrades leading to a "Reduce" consensus rating for the stock. Maximus recently reported quarterly EPS of $2.22, exceeding expectations, but revenue decreased by 5.1% year-over-year to $1.28 billion.
Maximus, Inc. $MMS Shares Sold by Bank of America Corp DE
Bank of America Corp DE reduced its stake in Maximus, Inc. (MMS) by 19.6% in the first quarter, selling 137,118 shares and retaining 563,486 shares valued at $36.1 million. Maximus reported quarterly EPS of $2.22, beating estimates, but revenue of $1.28 billion missed expectations and was down 5.1% year-over-year. The company also declared a quarterly dividend of $0.33, while analysts have given the stock an average "Reduce" rating.
Maximus (MMS): Fuller & Thaler Asset Management discloses 5.14% ownership stake
Fuller & Thaler Asset Management, Inc. has reported a beneficial ownership stake of 5.14% in MAXIMUS, INC. (MMS), holding 2,702,709.97 shares. The firm exercises sole voting power over 2,655,263.97 shares and sole dispositive power over all 2,702,709.97 beneficially owned shares. This disclosure was made via a SCHEDULE 13G SEC filing signed by Hanna Zanoni, Chief Compliance Officer.
Precision Trading with Maximus Inc. (MMS) Risk Zones
The article provides a detailed analysis of Maximus Inc. (MMS) with a focus on risk zones for precision trading. It highlights weak sentiment across all horizons, supporting a short bias, and outlines specific institutional trading strategies including long, breakout, and short positions with defined entry, target, and stop-loss levels. The analysis, generated by AI models, also includes multi-timeframe signal analysis indicating support and resistance levels.
Maximus (MMS) Q3 2026 Earnings Call Transcript
Maximus (MMS) reported Q3 2026 earnings, meeting revenue expectations but revising full-year EPS guidance downward due to a temporary suspension of performance incentives on a VA contract. Despite this, the company projects a return to positive organic growth in its U.S. Services segment in Q4 2026 and continues to prioritize technology investments, AI integration, and expansion into defense markets to diversify revenue and improve margins. Management expressed confidence in securing the VA MDE rebid and highlighted strong engagement in SNAP and Medicaid-related opportunities driven by H.R. 1 legislation.
Maximus (NYSE:MMS) Downgraded by Zacks Research to "Strong Sell"
Zacks Research has downgraded Maximus (NYSE:MMS) to a "Strong Sell" rating, with other analysts also lowering their assessments, resulting in an overall "Reduce" rating from MarketBeat. Maximus shares opened at $54.45, near their 12-month low, and the company reported quarterly EPS that slightly beat expectations but revenue that missed estimates and declined year-over-year. Institutional investors continue to hold a significant portion of the company's stock despite the downgrades and mixed financial performance.
Is Maximus Stock Worth Buying as Low Valuation Meets Contract Risk?
Maximus (MMS) stock trades at a deep earnings discount, but this reflects near-term uncertainty due to federal procurement delays and contract sensitivity. While the company has a strong sales pipeline and improved liquidity, its current Zacks Rank #5 (Strong Sell) and unfavorable earnings estimate trends suggest caution, despite attractive valuation and fundamental characteristics. The article advises patience until estimate trends improve.
Is Maximus Stock Worth Buying as Low Valuation Meets Contract Risk?
Maximus, Inc. (MMS) presents a complex investment case with a low valuation due to a deep earnings discount, but faces significant risks from federal procurement delays and contract sensitivity, leading to downward earnings estimate revisions. Despite a large sales pipeline, conversion risk is high, and while liquidity is stable, the company's Zacks Rank #5 (Strong Sell) suggests caution for investors until estimate trends improve.
Is Maximus Stock Worth Buying as Low Valuation Meets Contract Risk?
Maximus, Inc. (MMS) presents a complex investment case due to its deep earnings discount and favorable fundamental Style Scores, contrasted with near-term uncertainty stemming from federal procurement delays and contract sensitivity. The company's valuation is significantly lower than its industry and historical median, reflecting weaker growth visibility, despite solid earnings growth and efficiency initiatives. Investors are advised to exercise patience until earnings estimate trends improve, despite the attractive valuation and strong operational indicators.
Can Maximus Weather the VA Contract Hit and Rebuild Earnings Momentum?
Maximus, Inc. (MMS) faces a near-term earnings setback due to a temporary pause in performance incentives for a major Department of Veterans Affairs contract, which significantly contributed to profitability. This has led to a reduction in fiscal 2026 adjusted earnings and free cash flow guidance. While the company benefits from operating improvements in other segments and technology-driven efficiencies, the impact of federal contract changes highlights its sensitivity to government programs.
Enterprise value to revenue forward of Maximus, Inc. – NYSE:MMS
The article focuses on the enterprise value to revenue forward for Maximus, Inc. (NYSE: MMS) as presented on TradingView. It appears to be a financial data snippet, showing key information about the company's financials within the context of market data. The content is primarily a listing of navigation and footer elements from the TradingView platform, with the actual financial data point being the core focus.
Did Lowered 2026 Guidance After VA Incentive Pause Just Shift Maximus' (MMS) Investment Narrative?
Maximus, Inc. (MMS) recently updated its fiscal 2026 guidance to the lower end of previous estimates after the Department of Veterans Affairs paused performance incentives on its Medical Disability Exam program. This decision highlights the company's reliance on government contracts and how shifts in their structure can significantly impact earnings, even as quarterly margins improve. The revised outlook underscores the inherent risks in Maximus's investment narrative, particularly its dependency on a few highly structured contracts.
Did Lowered 2026 Guidance After VA Incentive Pause Just Shift Maximus' (MMS) Investment Narrative?
Maximus, Inc. (MMS) recently lowered its fiscal 2026 guidance following a pause in performance incentives on its VA Medical Disability Exam program. This decision highlights the company's reliance on structured government contracts, which can significantly impact earnings despite improving quarterly EPS and a strong pipeline. Investors should consider how this shift in contract terms affects Maximus' long-term investment narrative and analyst expectations.
Did Lowered 2026 Guidance After VA Incentive Pause Just Shift Maximus' (MMS) Investment Narrative?
Maximus, Inc. reported Q3 results and updated its fiscal 2026 guidance downwards due to a pause in performance incentives on its VA Medical Disability Exam program. This shift highlights the company's reliance on government contracts and how changes in these structures can significantly impact earnings, potentially reshaping its investment narrative despite improving quarterly EPS. The revised outlook suggests that even with a strong pipeline, contract modifications can temper full-year expectations and complicate the path to consistent earnings.
Janus Henderson Group PLC Decreases Holdings in Maximus, Inc. $MMS
Janus Henderson Group PLC significantly reduced its stake in Maximus, Inc. by 95.4% in the first quarter, selling nearly half a million shares. Despite this, Maximus exceeded fiscal Q3 EPS expectations but saw revenue decline year-over-year and lowered its fiscal 2026 EPS guidance, leading to an average "Hold" rating from analysts. The company also announced a quarterly dividend of $0.33 per share.
Maximus (NYSE:MMS) Announces Quarterly Earnings Results, Beats Expectations By $0.01 EPS
Maximus (NYSE:MMS) announced its quarterly earnings, reporting an adjusted EPS of $2.22, exceeding analyst expectations by $0.01, though revenue of $1.28 billion missed estimates and was down 5.1% year-over-year. The company lowered its fiscal 2026 adjusted EPS guidance to $7.90–$8.20, partially due to a temporary pause in VA Medical Disability Exam performance incentives. Despite the revenue miss and reduced profit outlook, Maximus maintains positive cash flow guidance and expects U.S. Services to return to mid-single-digit organic growth, driven by Medicaid-related outreach, AI solutions, and defense opportunities.
Reinhart Partners LLC. Purchases 1,127,346 Shares of Maximus, Inc. $MMS
Reinhart Partners LLC. significantly increased its stake in Maximus, Inc. (NYSE:MMS) by 131.8% in the second quarter, acquiring an additional 1.13 million shares to hold nearly 2 million shares valued at $106.6 million. This makes Maximus its 18th largest holding, representing 2.4% of its investment portfolio. The health services provider recently reported Q3 adjusted EPS of $2.22, beating estimates, but revenue fell 5.1% year-over-year to $1.28 billion and management reduced fiscal 2026 EPS guidance to $7.90–$8.20.
The Manufacturers Life Insurance Company Has $3.24 Million Stake in Maximus, Inc. $MMS
The Manufacturers Life Insurance Company significantly reduced its stake in Maximus, Inc. (NYSE:MMS) by 85.2% in the first quarter, now holding 50,540 shares valued at $3.24 million. Maximus reported fiscal Q3 adjusted EPS of $2.22, exceeding estimates, but revenue declined by 5.1% year-over-year to $1.28 billion, missing consensus. Analysts have largely maintained a "Hold" rating for the stock after recent downgrades, and the company issued a lower fiscal 2026 EPS guidance.
FMR LLC discloses 10.6% Maximus Inc (MMS) ownership in amended 13G
FMR LLC and Abigail P. Johnson have filed an amended Schedule 13G, disclosing a 10.6% beneficial ownership in Maximus Inc (MMS) common stock as of June 30, 2026. This equates to 5,544,431.76 shares, with FMR LLC holding sole voting power over 4,624,665.54 shares and sole dispositive power over all 5,544,431.76 shares. The filing indicates that other parties may have economic interests in these shares, but none exceed five percent of the class.
Maximus Q3 Earnings Beat Estimates, Increase Year Over Year
Maximus (MMS) reported mixed third-quarter fiscal 2026 results, with earnings beating estimates but revenues falling short. The company's adjusted earnings per share increased year-over-year, despite a decline in overall revenues due to factors like reduced natural disaster support and temporary clinical volume surges in the prior year. Maximus also lowered its fiscal 2026 earnings guidance due to a temporary contractual modification with a major federal customer.
Maximus, Inc. $MMS Stock Position Lifted by Quantinno Capital Management LP
Quantinno Capital Management LP significantly increased its stake in Maximus, Inc. by 413.1% in the first quarter, now holding 76,181 shares valued at approximately $4.9 million. This move comes as institutional investors collectively own 97.21% of the company. Maximus reported strong quarterly earnings of $2.22 per share, exceeding estimates, and declared a quarterly dividend of $0.33 per share, equivalent to a 2.3% yield, despite revenue falling short of expectations.
Maximus Q3 FY26 slides: margins expand but guidance cut on VA contract
Maximus (NYSE: MMS) reported Q3 FY26 results with margin expansion and an EPS beat, but cut its full-year profit outlook due to a temporary contractual modification with a major federal customer, causing its stock to drop by 10.85%. Despite the guidance cut, the company highlighted operational improvements, a substantial opportunity pipeline, and strategic growth initiatives in state programs, AI, and defense markets. Management expressed confidence in resolving cash flow timing challenges and reiterated long-term growth objectives.
Maximus: Fiscal Q3 Earnings Snapshot
Maximus Inc. (MMS) reported fiscal third-quarter net income of $103.6 million, or $1.95 per share. Adjusted earnings of $2.22 per share surpassed Wall Street expectations of $2.20 per share. However, the company's revenue of $1.28 billion missed forecasts, leading Maximus to project full-year revenue between $5.2 billion and $5.35 billion.
MaxHP to advance human performance for the modern warfighter
Maximus and Endurion have launched MaxHP, a strategic joint venture designed to optimize human performance for the United States Special Operations Command (USSOCOM) Enterprise. MaxHP aims to support warfighters and their families by integrating physical, cognitive, and behavioral readiness through embedded practitioners who understand the special operations environment. This initiative combines Maximus's infrastructure with Endurion's SOF-operator heritage to enhance mission readiness, resilience, and long-term force effectiveness.
Earnings Flash (MMS) Maximus, Inc. Reports Q3 Revenue $1.28B, Vs. FactSet Est of $1.33B
Maximus, Inc. (MMS) announced its Q3 revenue, reporting $1.28 billion, which fell short of FactSet's estimate of $1.33 billion. This earnings flash provides key financial figures for the company's recent quarter.
